Millions of people most vulnerable to COVID-19 are set to be offered a COVID booster vaccine from September to increase their protection ahead of winter.
New interim guidance from the Joint Committee on Vaccination and Immunisation (JCVI) sets out the priority list for who should get a third jab if a booster programme is needed.
The plans have been drawn up to ensure the NHS is prepared for any possible booster jab campaign while officials await more data on whether a third vaccine is required to bolster protection over the winter months.
It will coincide with the rollout of flu jabs, which health officials have said will be vital this winter as they prepare for a potentially difficult influenza season.Advertisement
The UK is the first country in the world to publish interim guidance on a COVID-19 vaccine booster campaign, though a number of other countries are considering proposals.
Health Secretary Sajid Javid said: "Our first COVID-19 vaccination programme is restoring freedom in this country, and our booster programme will protect this freedom.
"We are working with the NHS to make sure we can rapidly deliver this programme to maintain protection for people in the winter months."
He said the plan was designed to "keep the virus at bay" in winter, when restrictions should have fully eased.
The final JCVI advice will be published before September and will take into account the latest figures on coronavirus infections, as well as additional scientific data from trials and real-time surveillance of the effectiveness of the vaccines.
As most younger adults will receive their second COVID-19 vaccine dose in late summer, the benefits of booster vaccination in this group will be considered by the JCVI at a later time.
The JCVI's interim advice is that a third booster jab is offered to the following groups in two stages:
The following people should be offered a third dose COVID-19 booster vaccine and the annual influenza vaccine, as soon as possible from September 2021:
The following people should be offered a third COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the influenza vaccine where eligible: